Stock fact sheet · data as of
BlackRock Science and Technology Trust II (BSTZ): fair value, margin of safety and Wheel Score
Ticker symbol BSTZ · Financial Services · Asset Management · United States · Shares of beneficial interest (trust) · Value Income
BSTZ trades as shares of beneficial interest in BlackRock Science and Technology Trust II - a trust rather than a company.
Is BSTZ undervalued?
At 25.57 (close of 5 Nov 2026), BSTZ trades 94% below the GLS average fair value of 413.55. That average comes from 6 models run on the latest filings, and 6 of them land above the current price. Margins of safety over 30% are the exception rather than the rule across the ~7,400 stocks we value each night, so the number earns BlackRock Science and Technology Trust II the full Value points in the Wheel Score - and a closer look at what the market is pricing in.
There is a wide gap between DDM (60.53) and GLS Growth (916.15). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.
Ranked against every other company we cover, BSTZ is clearly cheaper than it is fast-growing, so the nightly engine files it under Value (value score 94, growth score 50, out of 100). It also carries the Income tag (Income = a dividend yield of 4% or more).
Nine valuation models for BSTZ
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | - | - | Present value of the projected free cash flows, discounted at the cost of capital; no value tonight |
| Graham Number | 108.25 | +323% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 855.99 | +3248% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 374.12 | +1363% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 916.15 | +3483% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | - | - | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight |
| Payback Time | - | - | Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight |
| DDM | 60.53 | +137% | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend |
| EPV | 166.28 | +550% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | -0.0597 | -100% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 0.0000 | -100% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
BlackRock Science and Technology Trust II scores 5 of 9 on the Piotroski F-score: a middling result that falls one point short of the "Piotroski 6 or more" Wheel Trade Filter. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. On durability BSTZ scores 5.9/10 on the GLS Moat - a middle reading; the Moat Score tab on the Quote page's Financials view shows which of the four parts hold it back.
Returns on capital are high - ROIC 18.1%, ROE 18.3%, ROA 17.9% - with debt at 0.01 times equity and negative free cash flow.
The dividend yield is high at 16.09% (payout ratio 17%). A yield this size is often the market's way of pricing a risk to the payout, so the health score and cash flow matter more than usual.
Institutional ownership scores 4/10, insider activity 9/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 5 / 9 | ROIC | 18.1% |
|---|---|---|---|
| GLS Moat | 5.9 / 10 | ROE | 18.3% |
| Debt / equity | 0.01 | ROA | 17.9% |
| Free-cash-flow yield | -2.4% | Payout ratio | 17% |
| Institutions | 4 / 10 | Insiders · Congress | 9 · 5 / 10 |
Wheel Score 31: No options
No options are listed on BlackRock Science and Technology Trust II in our nightly snapshot, so it fails the first Wheel Trade Filter (options that actually trade) (it reads 31, under 70) and is left out of every options scan; the fair value and health figures above are still useful for a plain stock position.
Volume runs at 213k shares a day on a market cap of $1.8B, with a beta of 1.52 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score rates that weak.
| Filter | Wheel Trade Filter | Result | Detail |
|---|---|---|---|
| 1 | Options that actually trade | Fails | no listed options |
| 2 | A real business, not a gamble | Passes | Profitable over the last twelve months - not a speculative stock, fund or note |
| 3 | Below fair value | Passes | Trading below the nine-model average fair value (margin of safety above 0) |
| 4 | Financially healthy | Fails | Piotroski 5/9 (under 6) |
| 5 | Can repay its debt | Passes | Long-term debt repaid from 3 years of operating cash flow or less (6 for real estate and utilities; banks and insurers are not judged on it) |
| 6 | No serious red flags | Passes | Red Flags score 60 or more out of 100 (earnings, margins, debt, analysts, filings and price checked the same way for every stock) |
| 7 | A premium worth selling | Fails | no implied volatility |
| 8 | Big enough | Passes | Market cap $1 billion or more |
| 9 | Not a penny stock | Passes | Share price $5 or more |
| How it ranks | Rating | From | |
|---|---|---|---|
| Value | Strong | 94% below fair value | |
| Premium | Weak | no option data | |
| Moat | Fair | moat 5.9/10 | |
| Health | Fair | Piotroski 5/9 | |
| Red Flags | Fair | not scored yet - half marks | |
| Option trading | Weak | no option volume data | |
| Stability | Weak | beta 1.52, $1.8B company |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.
Upcoming events
No upcoming earnings date is recorded for BSTZ in the nightly calendar. The shares go ex-dividend on 13 Nov 2026 (0.1625 per share), so a covered call sold before then carries a small early-assignment risk around that date.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Asset Management
The 12 companies below are the closest to BlackRock Science and Technology Trust II by market cap within the Asset Management industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| FMIJX FMI International Fund | 39.62 | 45.10 | +12% | 21No options | $1.8B |
| FMIYX FMI International Fund Institutional Class | 39.90 | 88.92 | +55% | 29No options | $1.8B |
| NUV Nuveen Municipal Value Fund, Inc. | 8.41 | 11.62 | +28% | 23No options | $1.7B |
| AHLPX American Beacon AHL Managed Futures Strategy Fund - Investor Class | 10.41 | 7.10 | -47% | 14No options | $1.8B |
| PTOAX PIMCO StocksPLUS Absolute Return Fund Class A | 13.00 | 6.80 | -91% | 10No options | $1.7B |
| CLM Cornerstone Strategic Value Fund, Inc. | 6.11 | 29.57 | +79% | 25No options | $1.7B |
| GLPIX Goldman Sachs MLP Energy Infrastructure Fund | 40.91 | - | - | 14No options | $1.7B |
| AHIVX American Century High Income Fund - Investor Class | 8.34 | 8.31 | -0% | 11No options | $1.8B |
| PDO Pimco Dynamic Income Opportunities Fund | 12.06 | 13.40 | +10% | 17No options | $1.7B |
| BDJ BlackRock Enhanced Equity Dividend Trust | 9.73 | 41.81 | +77% | 32No options | $1.7B |
| CDHAX Calvert International Responsible Idx A | 43.21 | 40.69 | -6% | 16No options | $1.7B |
| BMEZ BlackRock Health Sciences Term Trust | 17.85 | 69.30 | +74% | 32No options | $1.8B |
⚖ Compare BSTZ with 7 of them All Financial Services stocks →
Scan the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the top 10 stocks that pass all 9 Wheel Trade Filters, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about BSTZ
Is BSTZ undervalued right now?
By the GLS models, yes: at 25.57 the stock is 94% below the average fair value of 413.55 (data as of 5 Nov 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of BSTZ and what does it mean?
BSTZ has no listed options in our nightly snapshot, so it cannot be wheeled; it fails the first Wheel Trade Filter (options that actually trade), stays under 70 and is shown as "No options".
What is the GLS fair value for BSTZ?
413.55 per share as of 5 Nov 2026 - the simple average of the 6 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does BlackRock Science and Technology Trust II report earnings next?
No upcoming earnings date is recorded for BSTZ in our calendar as of 5 Nov 2026; the Calendars page is refreshed every morning.
Does BSTZ have listed options, and how liquid are they?
No. The nightly options snapshot found no listed contracts on BSTZ, so the wheel strategy cannot be run on it and the Wheel Score stays under 70.